Cryopyrin-associated periodic syndrome
Active Research Protocols
- 05-AR-0014 – Continuation of a Pilot Open-Label Study of IL 1 Trap in Adult Subjects with Autoinflammatory Diseases: A Therapeutic Approach to Study Pathogenesis
- 13-AR-0086 – A Pilot Open-Label Study of Rilonacept (Arcalyst) in the Deficiency of the Interleukin-1 Receptor Antagonist (DIRA)
NOTE: PDF documents require the freeAdobe Reader.
This page was last updated: January 24, 2014